Definitive Healthcare reveals findings from its AI-powered growth intelligence platform's early-adopter program, improving healthcare data analysis efficiency.
Quiver AI Summary
Definitive Healthcare has announced initial findings from its early-adopter program for its new AI-powered growth intelligence platform, which was launched in August 2026. This program provided a select group of customers, including health systems and life sciences organizations, with early access to the platform's capabilities, allowing them to perform over 570 analyses that significantly cut the time needed for data insights from weeks or months to minutes. The platform integrates various datasets for contextual insights, enabling users to tackle market growth, account prioritization, patient retention, market sizing, early interventions, and engaging with key experts. Participants, such as Bergen New Bridge Medical Center, reported improved decision-making and operational efficiency. General availability of the platform is planned for early 2027, with enhancements to automate workflows and surface growth opportunities. The platform is being showcased at the HLTH conference in Las Vegas from November 16-18.
Potential Positives
- Definitive Healthcare's AI-powered growth intelligence platform has successfully facilitated over 570 analyses for early adopters, showcasing its practical effectiveness and utility in the healthcare market.
- Participants have reported significant time savings, completing sophisticated analyses in minutes instead of weeks or months, which could lead to faster decision-making in healthcare organizations.
- The platform has integrated multiple datasets to provide contextual insights, enhancing the ability of users to understand complex healthcare relationships and market dynamics.
- The upcoming general availability planned for early 2027 indicates a positive trajectory for the company and the potential for broader adoption of their innovative solutions in the healthcare industry.
Potential Negatives
- While the early adoption program highlights the new AI platform, the general availability is not scheduled until early 2027, which may lead to missed opportunities in a competitive market.
- The reliance on early adopter feedback indicates that the platform might still have unaddressed issues or limitations that could impact overall effectiveness and user satisfaction.
- There is limited information on the actual market reception or performance metrics of the AI platform beyond the number of analyses conducted, raising concerns about its tangible impact on users' decision-making abilities.
FAQ
What is Definitive Healthcare's new AI-powered platform?
Definitive Healthcare's new AI-powered growth intelligence platform provides advanced analytics and data insights to enhance decision-making in healthcare.
When was the AI platform launched?
The AI platform was launched in August 2026 as part of an early-adopter program for select customers.
How many analyses have been conducted using the platform?
Participants have conducted over 570 analyses using the platform since its launch.
What are the benefits of using the AI platform?
The platform enables quicker data analysis, market intelligence, and informed decision-making, reducing analysis time from weeks to minutes.
When will the AI platform be generally available?
The general availability of Definitive Healthcare's AI-powered growth intelligence platform is planned for early 2027.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$DH Revenue
$DH had revenues of $54.6M in Q3 2026. This is a decrease of -8.99% from the same period in the prior year.
You can track DH financials on Quiver Quantitative's DH stock page.
You can access data on DH stock through the Quiver Quantitative API.
$DH Hedge Fund Activity
We have seen 29 institutional investors add shares of $DH stock to their portfolio, and 97 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BEARTOWN CAPITAL MANAGEMENT, LLC added 1,500,000 shares (+inf%) to their portfolio in Q3 2026, for an estimated $1,357,500
- KENNEDY CAPITAL MANAGEMENT LLC removed 1,332,669 shares (-76.7%) from their portfolio in Q3 2026, for an estimated $1,206,065
- BLACKROCK, INC. removed 565,357 shares (-40.1%) from their portfolio in Q3 2026, for an estimated $511,648
- RENAISSANCE TECHNOLOGIES LLC added 449,300 shares (+85.6%) to their portfolio in Q3 2026, for an estimated $406,616
- JANE STREET GROUP, LLC added 385,978 shares (+556.6%) to their portfolio in Q3 2026, for an estimated $349,310
- NORTHERN TRUST CORP removed 331,557 shares (-76.1%) from their portfolio in Q2 2026, for an estimated $275,490
- MILLENNIUM MANAGEMENT LLC removed 314,486 shares (-53.3%) from their portfolio in Q2 2026, for an estimated $261,306
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$DH Price Targets
Multiple analysts have issued price targets for $DH recently. We have seen 2 analysts offer price targets for $DH in the last 6 months, with a median target of $1.1.
Here are some recent targets:
- Craig Hettenbach from Morgan Stanley set a target price of $1.5 on 08/11/2026
- Allen Lutz from B of A Securities set a target price of $0.7 on 06/29/2026
Full Release
FRAMINGHAM, Mass., Nov. 16, 2026 (GLOBE NEWSWIRE) --
Definitive Healthcare
(Nasdaq: DH), a provider of healthcare data and analytics, today announced the initial findings of its early-adopter program for the company’s new AI-powered growth intelligence platform
announced earlier this year
.
Launched in August for a select group of customers, the program provided early access to the AI platform’s capabilities. Since then, participants have conducted more than 570 analyses using the platform. Health systems, life sciences organizations, and other healthcare-focused businesses have been able to answer complicated market questions and complete sophisticated analyses in minutes rather than the weeks or months traditionally required for data preparation, analysis, and insights generation.
As part of the early adopter program, users gained access to Definitive Healthcare’s provider, organization, claims, affiliation, and key opinion leader datasets connected for the first time within the AI-powered experience. By understanding the complex relationships across the healthcare ecosystem, the platform delivers contextual insights through a single conversational interface, making the full value of the company’s intelligence instantly accessible.
Participants across sales, marketing, operations, analytics, underwriting, and more have leveraged the AI platform to address a wide range of real-world use cases, including the ability to:
- Plan growth: Track market share, benchmark competition, and determine expansion plans with deep market intelligence.
- Prioritize the right accounts: Identify health systems and providers ready to buy, including key affiliations and decision makers.
- Retain patients: Quickly determine patient referral leakage patterns and plan new service lines to retain patients.
- Size market share: Group patients by patient journeys and treatments to accurately calculate a specific market size.
- Offer earlier interventions: Curate lists of physicians making specific diagnoses, but not yet prescribing drugs that could help patients earlier in their care journey.
- Engage the right experts: Find key influencers, plan congress strategy, and deploy medical science liaisons where they’ll have the most impact.
Bergen New Bridge Medical Center, the fourth largest publicly owned hospital in the United States, participated in the early adopter program.
“Having timely, useful information helps us make better decisions for the people we serve,” said Deborah Visconi, President and CEO of Bergen New Bridge Medical Center. “Definitive Healthcare’s new AI platform helps us better understand patient needs and explore opportunities to expand care. Our team can spend less time gathering and analyzing data and more time putting that information to work. For us, the value is in how it supports our commitment to bringing needed services into our community and making care more accessible.”
The medical center used the platform to explore solutions to expand access to care, strengthen provider relationships, and support strategic service line planning. As part of the early adopter program, Bergen New Bridge analyzed renal care and dialysis utilization patterns among patients connected to the healthcare provider to better understand care relationships and identify potential opportunities for outside collaboration. An analysis that could typically take weeks was condensed into hours or days, while providing deeper market understanding and building trust through greater data transparency.
“We’re seeing customers move from asking questions to taking action in the same conversation,” said Clay Ritchey, Chief Executive Officer of Definitive Healthcare. "By combining our trusted intelligence with AI, teams can explore opportunities, test strategies, and make decisions in minutes instead of weeks.”
General availability of Definitive Healthcare’s new AI-powered growth intelligence platform is planned for early 2027. Future enhancements will help teams automate repeatable workflows, proactively surface growth opportunities and market shifts, and embed intelligence directly into the systems where decisions are made.
Definitive Healthcare is showcasing the platform at HLTH in Las Vegas from November 16-18. Live product demonstrations will be available at the company’s booth:
Definitive Healthcare HLTH Booth Information:
Venetian Level 2:
Exhibit Hall – 4121
About Definitive Healthcare:
Definitive Healthcare
is the growth intelligence company focused on the business side of healthcare. The healthcare market is complex — our data makes it clearer. We cut through the noise to deliver the insights that healthcare organizations and companies need to make smarter, faster, more strategic decisions. Because when our customers succeed, healthcare gets better for everyone.
Media Contacts:
Bethany Swackhamer
Definitive Healthcare
[email protected]
Jeff Rusack
Sōvyn
[email protected]